Loading…
Validation of the DECA criteria for allergic conjunctivitis severity and control
Background Allergic conjunctivitis (AC) is usually associated to allergic rhinitis (AR), but the severity and control of ocular symptoms should be assessed independently to improve diagnosis and treatment. The criteria from the Spanish consensus document on allergic conjunctivitis (DECA) aimed to be...
Saved in:
| Published in: | Clinical and translational allergy 2020-10, Vol.10 (1), p.43-n/a, Article 43 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853 |
| container_end_page | n/a |
| container_issue | 1 |
| container_start_page | 43 |
| container_title | Clinical and translational allergy |
| container_volume | 10 |
| creator | Sánchez‐Hernández, M. Cesárea Navarro, Ana M. Colás, Carlos Cuvillo, Alfonso Sastre, Joaquín Mullol, Joaquim Valero, Antonio |
| description | Background
Allergic conjunctivitis (AC) is usually associated to allergic rhinitis (AR), but the severity and control of ocular symptoms should be assessed independently to improve diagnosis and treatment. The criteria from the Spanish consensus document on allergic conjunctivitis (DECA) aimed to be used as a patient‐reported instrument for AC management. Here we validate these criteria for classifying AC severity and defining its control following COSMIN guidelines recommendations.
Methods
Patients with moderate or severe AR [reflective total nasal symptom score (rTNSS) score ≥ 8] and concomitant AC were recruited from hospitals in Spain. Patients were classified according to the severity of ocular symptoms as mild, moderate, or severe, and classified with respect to control as controlled and non‐controlled, using the DECA criteria. To validate these criteria, comparisons with the validated modified allergic rhinitis and its impact on asthma (mARIA), reflective total ocular symptom score (rTOSS), rhinitis control assessment test (RCAT), ESPRINT‐15 questionnaires, a conjunctival hyperemia scale and a visual analogue scale (VAS) for ocular symptoms were performed.
Results
A total of 128 patients participated in the validation. Mean age was 34.4 ± 12.1 years; 72.7% were women. The DECA criteria showed a good discriminant validity, reflecting a high capacity to differentiate between mild, moderate, and severe patients, and controlled from uncontrolled patients. A strong association between AC and AR was reflected in the comparison between the DECA and the mARIA criteria (p |
| doi_str_mv | 10.1186/s13601-020-00349-4 |
| format | article |
| fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_05c92c3908a547a3af82df203965b1f6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A639526878</galeid><doaj_id>oai_doaj_org_article_05c92c3908a547a3af82df203965b1f6</doaj_id><sourcerecordid>A639526878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853</originalsourceid><addsrcrecordid>eNqNkl1v0zAUhiMEYtPYH-ACRUJC3GT4O7aQkLqywaRKcDG4tRx_tK7ceNhJUf897jJGi7ggjhzL5zlv7HPeqnoJwQWEnL3LEDMAG4BAAwAmoiFPqlMECG1agNDTg_VJdZ7zGpSHcljm59UJxhACIuBp9fW7Ct6owce-jq4eVrb-eDWf1Tr5wSavahdTrUKwael1rWO_Hns9-K0ffK6z3RZm2NWqN_vYkGJ4UT1zKmR7_vA9q75dX93OPzeLL59u5rNFoxlhbcMsN4QxgQXsus50zhDaKY45g8IQQIyGRhGgrWshItbhMhwQWLe2pZhTfFbdTLomqrW8S36j0k5G5eX9RkxLqdLgdbASUC2QxgJwRUmrsHIcGYcAFox20LGi9WHSuhu7jTXalpuocCR6HOn9Si7jVraUU9juBd4-CKT4Y7R5kBuftQ1B9TaOWSJCC1deXNDXf6HrOKa-lKpQrHSWUgz-UEtVLuB7F8t_9V5UzhgWFDHe8kJd_IMqw9iNL_2wzpf9o4Q3Bwkrq8KwyjGM-_bnYxBNoE4x52TdYzEgkHv_ycl_svhP3vtPkpL06rCMjym_3VaA9xPws5xr9x-Scr64RZfXAArS4l-dnuP8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2461865530</pqid></control><display><type>article</type><title>Validation of the DECA criteria for allergic conjunctivitis severity and control</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Sánchez‐Hernández, M. Cesárea ; Navarro, Ana M. ; Colás, Carlos ; Cuvillo, Alfonso ; Sastre, Joaquín ; Mullol, Joaquim ; Valero, Antonio</creator><creatorcontrib>Sánchez‐Hernández, M. Cesárea ; Navarro, Ana M. ; Colás, Carlos ; Cuvillo, Alfonso ; Sastre, Joaquín ; Mullol, Joaquim ; Valero, Antonio</creatorcontrib><description>Background
Allergic conjunctivitis (AC) is usually associated to allergic rhinitis (AR), but the severity and control of ocular symptoms should be assessed independently to improve diagnosis and treatment. The criteria from the Spanish consensus document on allergic conjunctivitis (DECA) aimed to be used as a patient‐reported instrument for AC management. Here we validate these criteria for classifying AC severity and defining its control following COSMIN guidelines recommendations.
Methods
Patients with moderate or severe AR [reflective total nasal symptom score (rTNSS) score ≥ 8] and concomitant AC were recruited from hospitals in Spain. Patients were classified according to the severity of ocular symptoms as mild, moderate, or severe, and classified with respect to control as controlled and non‐controlled, using the DECA criteria. To validate these criteria, comparisons with the validated modified allergic rhinitis and its impact on asthma (mARIA), reflective total ocular symptom score (rTOSS), rhinitis control assessment test (RCAT), ESPRINT‐15 questionnaires, a conjunctival hyperemia scale and a visual analogue scale (VAS) for ocular symptoms were performed.
Results
A total of 128 patients participated in the validation. Mean age was 34.4 ± 12.1 years; 72.7% were women. The DECA criteria showed a good discriminant validity, reflecting a high capacity to differentiate between mild, moderate, and severe patients, and controlled from uncontrolled patients. A strong association between AC and AR was reflected in the comparison between the DECA and the mARIA criteria (p < 0.0001). The DECA criteria for severity and control presented satisfactory properties for longitudinal validity and responsiveness.
Conclusions
Validation of the DECA criteria for severity and control of AC suggested that it can be useful in the evaluation of eye symptoms and follow‐up of therapies.</description><identifier>ISSN: 2045-7022</identifier><identifier>EISSN: 2045-7022</identifier><identifier>DOI: 10.1186/s13601-020-00349-4</identifier><identifier>PMID: 33110491</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Allergic conjunctivitis ; Allergic rhinoconjunctivitis ; Analysis ; Asthma ; Care and treatment ; Classification ; Conjunctivitis ; Conjunctivitis classification ; Control ; Disease ; Hay fever ; Ocular allergy ; Patients ; Pruritus ; Quality of life ; Questionnaires ; Rhinitis</subject><ispartof>Clinical and translational allergy, 2020-10, Vol.10 (1), p.43-n/a, Article 43</ispartof><rights>2020 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology</rights><rights>The Author(s) 2020.</rights><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853</citedby><cites>FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853</cites><orcidid>0000-0001-7722-6057</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2461865530/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2461865530?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33110491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez‐Hernández, M. Cesárea</creatorcontrib><creatorcontrib>Navarro, Ana M.</creatorcontrib><creatorcontrib>Colás, Carlos</creatorcontrib><creatorcontrib>Cuvillo, Alfonso</creatorcontrib><creatorcontrib>Sastre, Joaquín</creatorcontrib><creatorcontrib>Mullol, Joaquim</creatorcontrib><creatorcontrib>Valero, Antonio</creatorcontrib><title>Validation of the DECA criteria for allergic conjunctivitis severity and control</title><title>Clinical and translational allergy</title><addtitle>Clin Transl Allergy</addtitle><description>Background
Allergic conjunctivitis (AC) is usually associated to allergic rhinitis (AR), but the severity and control of ocular symptoms should be assessed independently to improve diagnosis and treatment. The criteria from the Spanish consensus document on allergic conjunctivitis (DECA) aimed to be used as a patient‐reported instrument for AC management. Here we validate these criteria for classifying AC severity and defining its control following COSMIN guidelines recommendations.
Methods
Patients with moderate or severe AR [reflective total nasal symptom score (rTNSS) score ≥ 8] and concomitant AC were recruited from hospitals in Spain. Patients were classified according to the severity of ocular symptoms as mild, moderate, or severe, and classified with respect to control as controlled and non‐controlled, using the DECA criteria. To validate these criteria, comparisons with the validated modified allergic rhinitis and its impact on asthma (mARIA), reflective total ocular symptom score (rTOSS), rhinitis control assessment test (RCAT), ESPRINT‐15 questionnaires, a conjunctival hyperemia scale and a visual analogue scale (VAS) for ocular symptoms were performed.
Results
A total of 128 patients participated in the validation. Mean age was 34.4 ± 12.1 years; 72.7% were women. The DECA criteria showed a good discriminant validity, reflecting a high capacity to differentiate between mild, moderate, and severe patients, and controlled from uncontrolled patients. A strong association between AC and AR was reflected in the comparison between the DECA and the mARIA criteria (p < 0.0001). The DECA criteria for severity and control presented satisfactory properties for longitudinal validity and responsiveness.
Conclusions
Validation of the DECA criteria for severity and control of AC suggested that it can be useful in the evaluation of eye symptoms and follow‐up of therapies.</description><subject>Allergic conjunctivitis</subject><subject>Allergic rhinoconjunctivitis</subject><subject>Analysis</subject><subject>Asthma</subject><subject>Care and treatment</subject><subject>Classification</subject><subject>Conjunctivitis</subject><subject>Conjunctivitis classification</subject><subject>Control</subject><subject>Disease</subject><subject>Hay fever</subject><subject>Ocular allergy</subject><subject>Patients</subject><subject>Pruritus</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Rhinitis</subject><issn>2045-7022</issn><issn>2045-7022</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl1v0zAUhiMEYtPYH-ACRUJC3GT4O7aQkLqywaRKcDG4tRx_tK7ceNhJUf897jJGi7ggjhzL5zlv7HPeqnoJwQWEnL3LEDMAG4BAAwAmoiFPqlMECG1agNDTg_VJdZ7zGpSHcljm59UJxhACIuBp9fW7Ct6owce-jq4eVrb-eDWf1Tr5wSavahdTrUKwael1rWO_Hns9-K0ffK6z3RZm2NWqN_vYkGJ4UT1zKmR7_vA9q75dX93OPzeLL59u5rNFoxlhbcMsN4QxgQXsus50zhDaKY45g8IQQIyGRhGgrWshItbhMhwQWLe2pZhTfFbdTLomqrW8S36j0k5G5eX9RkxLqdLgdbASUC2QxgJwRUmrsHIcGYcAFox20LGi9WHSuhu7jTXalpuocCR6HOn9Si7jVraUU9juBd4-CKT4Y7R5kBuftQ1B9TaOWSJCC1deXNDXf6HrOKa-lKpQrHSWUgz-UEtVLuB7F8t_9V5UzhgWFDHe8kJd_IMqw9iNL_2wzpf9o4Q3Bwkrq8KwyjGM-_bnYxBNoE4x52TdYzEgkHv_ycl_svhP3vtPkpL06rCMjym_3VaA9xPws5xr9x-Scr64RZfXAArS4l-dnuP8</recordid><startdate>20201023</startdate><enddate>20201023</enddate><creator>Sánchez‐Hernández, M. Cesárea</creator><creator>Navarro, Ana M.</creator><creator>Colás, Carlos</creator><creator>Cuvillo, Alfonso</creator><creator>Sastre, Joaquín</creator><creator>Mullol, Joaquim</creator><creator>Valero, Antonio</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7722-6057</orcidid></search><sort><creationdate>20201023</creationdate><title>Validation of the DECA criteria for allergic conjunctivitis severity and control</title><author>Sánchez‐Hernández, M. Cesárea ; Navarro, Ana M. ; Colás, Carlos ; Cuvillo, Alfonso ; Sastre, Joaquín ; Mullol, Joaquim ; Valero, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allergic conjunctivitis</topic><topic>Allergic rhinoconjunctivitis</topic><topic>Analysis</topic><topic>Asthma</topic><topic>Care and treatment</topic><topic>Classification</topic><topic>Conjunctivitis</topic><topic>Conjunctivitis classification</topic><topic>Control</topic><topic>Disease</topic><topic>Hay fever</topic><topic>Ocular allergy</topic><topic>Patients</topic><topic>Pruritus</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Rhinitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez‐Hernández, M. Cesárea</creatorcontrib><creatorcontrib>Navarro, Ana M.</creatorcontrib><creatorcontrib>Colás, Carlos</creatorcontrib><creatorcontrib>Cuvillo, Alfonso</creatorcontrib><creatorcontrib>Sastre, Joaquín</creatorcontrib><creatorcontrib>Mullol, Joaquim</creatorcontrib><creatorcontrib>Valero, Antonio</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley Online Library Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Clinical and translational allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez‐Hernández, M. Cesárea</au><au>Navarro, Ana M.</au><au>Colás, Carlos</au><au>Cuvillo, Alfonso</au><au>Sastre, Joaquín</au><au>Mullol, Joaquim</au><au>Valero, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of the DECA criteria for allergic conjunctivitis severity and control</atitle><jtitle>Clinical and translational allergy</jtitle><addtitle>Clin Transl Allergy</addtitle><date>2020-10-23</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>43</spage><epage>n/a</epage><pages>43-n/a</pages><artnum>43</artnum><issn>2045-7022</issn><eissn>2045-7022</eissn><abstract>Background
Allergic conjunctivitis (AC) is usually associated to allergic rhinitis (AR), but the severity and control of ocular symptoms should be assessed independently to improve diagnosis and treatment. The criteria from the Spanish consensus document on allergic conjunctivitis (DECA) aimed to be used as a patient‐reported instrument for AC management. Here we validate these criteria for classifying AC severity and defining its control following COSMIN guidelines recommendations.
Methods
Patients with moderate or severe AR [reflective total nasal symptom score (rTNSS) score ≥ 8] and concomitant AC were recruited from hospitals in Spain. Patients were classified according to the severity of ocular symptoms as mild, moderate, or severe, and classified with respect to control as controlled and non‐controlled, using the DECA criteria. To validate these criteria, comparisons with the validated modified allergic rhinitis and its impact on asthma (mARIA), reflective total ocular symptom score (rTOSS), rhinitis control assessment test (RCAT), ESPRINT‐15 questionnaires, a conjunctival hyperemia scale and a visual analogue scale (VAS) for ocular symptoms were performed.
Results
A total of 128 patients participated in the validation. Mean age was 34.4 ± 12.1 years; 72.7% were women. The DECA criteria showed a good discriminant validity, reflecting a high capacity to differentiate between mild, moderate, and severe patients, and controlled from uncontrolled patients. A strong association between AC and AR was reflected in the comparison between the DECA and the mARIA criteria (p < 0.0001). The DECA criteria for severity and control presented satisfactory properties for longitudinal validity and responsiveness.
Conclusions
Validation of the DECA criteria for severity and control of AC suggested that it can be useful in the evaluation of eye symptoms and follow‐up of therapies.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>33110491</pmid><doi>10.1186/s13601-020-00349-4</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7722-6057</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2045-7022 |
| ispartof | Clinical and translational allergy, 2020-10, Vol.10 (1), p.43-n/a, Article 43 |
| issn | 2045-7022 2045-7022 |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_05c92c3908a547a3af82df203965b1f6 |
| source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Open Access; PubMed Central |
| subjects | Allergic conjunctivitis Allergic rhinoconjunctivitis Analysis Asthma Care and treatment Classification Conjunctivitis Conjunctivitis classification Control Disease Hay fever Ocular allergy Patients Pruritus Quality of life Questionnaires Rhinitis |
| title | Validation of the DECA criteria for allergic conjunctivitis severity and control |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A17%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20the%20DECA%20criteria%20for%20allergic%20conjunctivitis%20severity%20and%20control&rft.jtitle=Clinical%20and%20translational%20allergy&rft.au=S%C3%A1nchez%E2%80%90Hern%C3%A1ndez,%20M.%20Ces%C3%A1rea&rft.date=2020-10-23&rft.volume=10&rft.issue=1&rft.spage=43&rft.epage=n/a&rft.pages=43-n/a&rft.artnum=43&rft.issn=2045-7022&rft.eissn=2045-7022&rft_id=info:doi/10.1186/s13601-020-00349-4&rft_dat=%3Cgale_doaj_%3EA639526878%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6467-6e8d4669391bbbdbfd45ba838619d404dc1da40cef7124ef3f3ff093c7e753853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2461865530&rft_id=info:pmid/33110491&rft_galeid=A639526878&rfr_iscdi=true |